Stockreport

Protalix BioTherapeutics to Present at the Life Sciences Investor Forum September 19, 2024

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF CARMIEL, Israel, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, product [Read more]